CLINICAL TRIALS PROFILE FOR TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
✉ Email this page to a colleague
All Clinical Trials for TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00313807 ↗ | Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage | Withdrawn | Queen's University | Phase 2 | 2005-11-01 | Exposure to radiographic contrast dye during coronary angiography is well known to cause either transient decreases in renal function or acute renal failure. Although the overall incidence is low, acute renal failure occurs most frequently in patients with both diabetes and chronic renal failure where the average reported incidence is upwards of 20%. The etiology of contrast-induced nephropathy is related to acute decline in renal blood flow following dye exposure resulting in ischemic injury at the level of the medulla. The development of acute renal failure following radiocontrast dye administration is significant because it contributes to morbidity and mortality in patients at risk. The administration of amino acids, either through intravenous infusion or a protein meal, results in a substantial increase in renal plasma flow (RPF) and glomerular filtration rate (GFR). In both healthy subjects and in those with chronic renal failure, an amino acid infusion produces a 20% rise in GFR and effective RPF. We hypothesize that the 20% rise in effective RPF and GFR following an amino acid infusion will counteract the radiocontrast dye-induced vasoconstriction and reduce the renal toxicity of contrast medium in a group of high-risk patients. |
| NCT02032953 ↗ | Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia | Active, not recruiting | Canadian Institutes of Health Research (CIHR) | Phase 4 | 2013-12-01 | The purpose of this study is to find out whether adding insulin after current colorectal cancer surgery promotes making and keeping proteins in the body, and to find out whether or not this effect can be further increased by increasing the amount of protein given. |
| NCT02032953 ↗ | Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia | Active, not recruiting | McGill University Health Center | Phase 4 | 2013-12-01 | The purpose of this study is to find out whether adding insulin after current colorectal cancer surgery promotes making and keeping proteins in the body, and to find out whether or not this effect can be further increased by increasing the amount of protein given. |
| NCT02032953 ↗ | Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia | Active, not recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 | 2013-12-01 | The purpose of this study is to find out whether adding insulin after current colorectal cancer surgery promotes making and keeping proteins in the body, and to find out whether or not this effect can be further increased by increasing the amount of protein given. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
Condition Name
Clinical Trial Locations for TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
Clinical Trial Progress for TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
Clinical Trial Phase
Clinical Trial Sponsors for TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
Sponsor Name
| Sponsor Name for TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER | |
| Sponsor | Trials |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Queen's University | 1 |
| Canadian Institutes of Health Research (CIHR) | 1 |
| [disabled in preview] | 1 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
